1921
Volume 97, Issue 1
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

We conducted an observational study to describe the characteristics of infective endocarditis (IE) in French West Indies (FWI) and to identify variables associated with in-hospital case fatality. The records of the patients admitted for IE to the University Hospital of Martinique between 2000 and 2012 were collected using an electronic case report form. Only Duke-Li definite cases were considered for this analysis. Variables associated with in-hospital mortality were tested using univariate logistic regression analysis. The analysis included 201 patients (median age 58 years, sex ratio: two males to one female). There was no previously known heart disease in 45.8%, a prosthetic valve in 21.4%, and previously known native valve disease in 32.8% of the cases. Community-acquired IE represented 59.7% of all cases, health-care-associated IE represented 38.3% and injection-drug-use-acquired IE represented 1.5%. Locations of IE were distributed as follows: 42.3% were mitral valve IE, 34.8% were aortic valve IE, and 7% were right-sided IE. Microorganisms recovered from blood cultures included 30.4% streptococci, 28.9% staphylococci, and 5% enterococci. Blood cultures were negative in 20.9% of the cases. Surgical treatment was performed in 53% of the patients. In-hospital case fatality rate was 19%. Advanced age, IE, and health-care-associated IE were associated with in-hospital case fatality. The epidemiological and microbiological profile of IE in FWI is in between those observed in developed countries and developing countries: patients were younger, blood cultures were more frequently negative, and IE due to group D streptococci and enterococci were less common than in industrialized countries.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.16-0514
2017-07-12
2018-10-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/97/1/tpmd160514.html?itemId=/content/journals/10.4269/ajtmh.16-0514&mimeType=html&fmt=ahah

References

  1. Osler W, , 1885. The Gulstonian lectures, on malignant endocarditis. BMJ 1: 467470.[Crossref]
  2. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, Moreillon P, de Jesus Antunes M, Thilen U, Lekakis J, Lengyel M, Müller L, Naber CK, Nihoyannopoulos P, Moritz A, Zamorano JL, ESC Committee for Practice Guidelines, 2009. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30: 23692413.[Crossref]
  3. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Jr Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH, International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS) Investigators, 2009. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 169: 463473.[Crossref]
  4. Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, Casalta JP, Danchin N, Delahaye F, Etienne J, Le Moing V, Leport C, Mainardi JL, Ruimy R, Vandenesch F, Association pour l’Etude et la Prévention de l’Endocardite Infectieuse (AEPEI) Study Group, 2002. Changing profile of infective endocarditis: results of a 1-year survey in France. JAMA 288: 7581.[Crossref]
  5. Duval X, Delahaye F, Alla F, Tattevin P, Obadia JF, Le Moing V, Doco-Lecompte T, Celard M, Poyart C, Strady C, Chirouze C, Bes M, Cambau E, Iung B, Selton-Suty C, Hoen B, AEPEI Study Group, 2012. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol 59: 19681976.[Crossref]
  6. Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B, AEPEI Study Group, 2012. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54: 12301239.[Crossref]
  7. Thuny F, Grisoli D, Collart F, Habib G, Raoult D, , 2012. Management of infective endocarditis: challenges and perspectives. Lancet 379: 965975.[Crossref]
  8. Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, Tleyjeh IM, , 2014. Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart 9: 131143.[Crossref]
  9. Cahill TJ, Prendergast BD, , 2016. Infective endocarditis. Lancet 387: 882893.[Crossref]
  10. Bannay A, Hoen B, Duval X, Obadia JF, Selton-Suty C, Le Moing V, Tattevin P, Iung B, Delahaye F, Alla F, AEPEI Study Group, 2011. The impact of valve surgery on short- and long-term mortality in left-sided infective endocarditis: do differences in methodological approaches explain previous conflicting results? Eur Heart J 32: 20032015.[Crossref]
  11. Hoen B, Duval X, , 2013. Clinical practice. Infective endocarditis. N Engl J Med 368: 14251433.[Crossref]
  12. Delahaye F, Chu VH, Altclas J, Barsic B, Delahaye A, Freiberger T, Gordon DL, Hannan MM, Hoen B, Kanj SS, Lejko-Zupanc T, Mestres CA, Pachirat O, Pappas P, Lamas C, Selton-Suty C, Tan R, Tattevin P, Wang A, International Collaboration on Endocarditis Prospective Cohort Study (ICE-PCS) Investigators, 2015. One-year outcome following biological or mechanical valve replacement for infective endocarditis. Int J Cardiol 178: 117123.[Crossref]
  13. Munoz P, Kestler M, De Alarcon A, Miro JM, Bermejo J, Rodríguez-Abella H, Fariñas MC, Cobo Belaustegui M, Mestres C, Llinares P, Goenaga M, Navas E, Oteo JA, Tarabini P, Bouza E, Spanish Collaboration on Endocarditis-Grupo de Apoyo al Manejo de la Endocarditis Infecciosa en España (GAMES), 2015. Current epidemiology and outcome of infective endocarditis: a multicenter, prospective, cohort Study. Medicine (Baltimore) 94: e1816.[Crossref]
  14. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, Woods CW, Reller LB, Ryan T, Fowler VG, Jr, 2002. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 162: 9094.[Crossref]
  15. Naimi TS, LeDell KH, Como-Sabetti K, Borchardt SM, Boxrud DJ, Etienne J, Johnson SK, Vandenesch F, Fridkin S, O’Boyle C, Danila RN, Lynfield R, , 2003. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290: 29762984.[Crossref]
  16. Fowler VG, Jr Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS, Investigators ICE, 2005. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 293: 30123021.[Crossref]
  17. Le Moing V, Alla F, Doco-Lecompte T, Delahaye F, Piroth L, Chirouze C, Tattevin P, Lavigne JP, Erpelding ML, Hoen B, Vandenesch F, Duval X, VIRSTA Study Group, 2015. Staphylococcus aureus bloodstream infection and endocarditis: a prospective cohort study. PLoS One 10: e0127385.[Crossref]
  18. Cabell CH, Abrutyn E, , 2002. Progress toward a global understanding of infective endocarditis. Early lessons from the International Collaboration on Endocarditis investigation. Infect Dis Clin North Am 16: 255–272 vii.
  19. Letaief A, Boughzala E, Kaabia N, Ernez S, Abid F, Ben Chaabane T, Ben Jemaa M, Boujnah R, Chakroun M, Daoud M, Gaha R, Kafsi N, Khalfallah A, Slimane L, Zaouali M, , 2007. Epidemiology of infective endocarditis in Tunisia: a 10-year multicenter retrospective study. Int J Infect Dis 11: 430433.[Crossref]
  20. Nkomo VT, , 2007. Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa. Heart 93: 15101519.[Crossref]
  21. Nunes MC, Gelape CL, Ferrari TC, , 2010. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis 14: e394e398.[Crossref]
  22. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG, Jr Ryan T, Bashore T, Corey GR, , 2000. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30: 633638.[Crossref]
  23. Bach JF, Chalons S, Forier E, Elana G, Jouanelle J, Kayemba S, Delbois D, Mosser A, Saint-Aime C, Berchel C, , 1996. 10-year educational programme aimed at rheumatic fever in two French Caribbean islands. Lancet 347: 644648.[Crossref]
  24. Garcia-Granja PE, Lopez J, Vilacosta I, Ortiz-Bautista C, Sevilla T, Olmos C, Sarriá C, Ferrera C, Gómez I, Román JA, , 2015. Polymicrobial infective endocarditis: clinical features and prognosis. Medicine (Baltimore) 94: e2000.[Crossref]
  25. Coard KC, Skeete DH, , 2003. Infective endocarditis at the University Hospital of the West Indies. A revisit. West Indian Med J 52: 235239.
  26. Grangier C, Debin M, Ardillon V, Mahamat A, Fournier PE, Simonnet C, Guillot G, Louvel D, Ravachol F, Perenhou V, Queuche F, Legrand E, Djossou F, Quénel P, Morvan J, Meynard JB, , 2009. Epidémiologie de la fièvre Q en Guyane, 1990–2006. Bulletin de Veille Sanitaire n°10 2009: 24.
  27. Edouard S, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D, , 2014. Comparison between emerging Q fever in French Guiana and endemic Q fever in Marseille, France. Am J Trop Med Hyg 90: 915919.[Crossref]
  28. Eldin C, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D, , 2014. Q fever in French Guiana. Am J Trop Med Hyg 91: 771776.[Crossref]
  29. da Costa PS, Brigatte ME, Greco DB, , 2005. Antibodies to Rickettsia rickettsii, Rickettsia typhi, Coxiella burnetii, Bartonella henselae, Bartonella quintana, and Ehrlichia chaffeensis among healthy population in Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 100: 853859.[Crossref]
  30. Lamas CC, Mares-Guia MA, Rozental T, Moreira N, Favacho AR, Barreira J, Guterres A, Bóia MN, de Lemos ER, , 2010. Bartonella spp. infection in HIV positive individuals, their pets and ectoparasites in Rio de Janeiro, Brazil: serological and molecular study. Acta Trop 115: 137141.[Crossref]
  31. Frankel D, Richet H, Renvoise A, Raoult D, , 2011. Q fever in France, 1985–2009. Emerg Infect Dis 17: 350356.[Crossref]
  32. Raoult D, Casalta JP, Richet H, Khan M, Bernit E, Rovery C, Branger S, Gouriet F, Imbert G, Bothello E, Collart F, Habib G, , 2005. Contribution of systematic serological testing in diagnosis of infective endocarditis. J Clin Microbiol 43: 52385242.[Crossref]
  33. Ellis ME, Al-Abdely H, Sandridge A, Greer W, Ventura W, , 2001. Fungal endocarditis: evidence in the world literature, 1965–1995. Clin Infect Dis 32: 5062.[Crossref]
  34. Bhatti S, Vilenski L, Tight R, Smego RA, Jr, 2005. Histoplasma endocarditis: clinical and mycologic features and outcomes. J Infect 51: 29.[Crossref]
  35. Kauffman CA, , 2007. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev 20: 115132.[Crossref]
  36. Aksoy O, Sexton DJ, Wang A, Pappas PA, Kourany W, Chu V, Fowler VG, Jr Woods CW, Engemann JJ, Corey GR, Harding T, Cabell CH, , 2007. Early surgery in patients with infective endocarditis: a propensity score analysis. Clin Infect Dis 44: 364372.[Crossref]
  37. Tleyjeh IM, Ghomrawi HM, Steckelberg JM, Hoskin TL, Mirzoyev Z, Anavekar NS, Enders F, Moustafa S, Mookadam F, Huskins WC, Wilson WR, Baddour LM, , 2007. The impact of valve surgery on 6-month mortality in left-sided infective endocarditis. Circulation 115: 17211728.[Crossref]
  38. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V, Delahaye F, Durante-Mangoni E, Edathodu J, Falces C, Logar M, Miró JM, Naber C, Tripodi MF, Murdoch DR, Moreillon P, Utili R, Wang A, , 2011. Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure. JAMA 306: 22392247.[Crossref]
  39. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC, Song JM, Choo SJ, Chung CH, Song JK, Lee JW, Sohn DW, , 2012. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 366: 24662473.[Crossref]
  40. Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V, Poyart C, Alla F, Cambau E, Tattevin P, Chirouze C, Obadia JF, Duval X, Hoen B, AEPEI Study Group, 2016. Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 37: 840848.[Crossref]
  41. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL, Reviewers Document, Erol Ç, Nihoyannopoulos P, Aboyans V, Agewall S, Athanassopoulos G, Aytekin S, Benzer W, Bueno H, Broekhuizen L, Carerj S, Cosyns B, De Backer J, De Bonis M, Dimopoulos K, Donal E, Drexel H, Flachskampf FA, Hall R, Halvorsen S, Hoen B, Kirchhof P, Lainscak M, Leite-Moreira AF, Lip GY, Mestres CA, Piepoli MF, Punjabi PP, Rapezzi C, Rosenhek R, Siebens K, Tamargo J, Walker DM, , 2015. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 36: 30753128.[Crossref]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.16-0514
Loading
/content/journals/10.4269/ajtmh.16-0514
Loading

Data & Media loading...

  • Received : 22 Jun 2016
  • Accepted : 15 Feb 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error